View online Forward to a friend   |   Facebook   |   Twitter
Editorial Focus:
Solid Oral Dose Formulation
Pharmaceutical Outsourcing™
Featured Articles   |   Featured Partners   |   Videos   |   Industry News   |   Events
December 04, 2024
LEARN MORE »
Newsletter Sponsor
   Take Action Against Nitrosamine Risks

Nitrosamine contamination in pharmaceuticals is a growing concern due to the potential carcinogenic risks. The FDA has been actively addressing this issue, especially regarding Nitrosamine Drug Substance-Related Impurities (NDSRIs). Discover how Adare Pharma Solutions developed an effective process to mitigate these impurities and ensure the safety of commercial products.

more info

» Industry News
learn more
  N4 Pharma Announces Pre-Clinical Development of an Oral RNA IBD Treatment
N4 Pharma Plc announced a new lead program N4 101. This orally-delivered inflammation inhibitor for ... read more »
learn more
  Merck’s WELIREG® Approved in China for Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors
Merck announced that the National Medical Products Administration (NMPA) in China has approved ... read more »
learn more
  Univar Solutions Named Exclusive Distributor of SD Head USA Pharmaceutical Excipients in North America
Univar Solutions LLC announced its selection as the sole channel partner for SD Head USA for the ... read more »

more news
 
» Featured Articles
EVENT   A New Framework for Identifying Nitrosamine Risks and Efficiently Derisking Products
Since the release of the FDA’s guidance on Nitrosamine Drug Substance-Related Impurities (... read more »
EVENT   Combining Patient Centricity and Commercial Viability in Pediatric Product Development
Medication acceptance and adherence are critical concerns in pediatric populations due to ... read more »
EVENT   Meeting the Challenges of Pediatric Adherence With Patient-centric Formulations
Developing effective therapies for pediatric populations involves unique and complex ... read more »
EVENT   Overcoming Barriers to Patient Adherence with a Novel Dosage Form
To make administration of an effective drug treatment easier for patients with hand ... read more »
more articles
 
» Featured Video
learn more
  A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules,... read more »

more videos
 
| Events
EVENT
  Interphex 2025
New York City, New York –  04/01/2025
INTERPHEX, the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference. event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA